Abbott (ABT) Tops Q4 EPS by 1c, Offers FY18 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Abbott Labs (ABT) PT Raised to $68 at Leerink Partners
January 25, 2018 7:16 AM ESTLeerink Partners raised its price target on Abbott Labs (NYSE: ABT) to $68.00 (from $60.00) while maintaining a Outperform rating.
... MoreAbbott Labs (ABT) PT Raised to $71 at Stifel
January 24, 2018 4:42 PM ESTStifel raised its price target on Abbott Labs (NYSE: ABT) to $71.00 (from $63.00) while maintaining a Buy rating following strong Q4 results.
Analyst Rick Wise said the company has significant and sustainable momentum heading into 2018.
... MoreAbbott Labs (ABT) PT Raised to $67 at Evercore ISI
January 24, 2018 12:34 PM ESTEvercore ISI raised its price target on Abbott Labs (NYSE: ABT) to $67.00 (from $64.00) while maintaining a Outperform rating.
The firm raised FY2018 EPS from $2.82 to $2.87, trimmed FY 2019 from $3.23 to $3.22 and raised FY 2020 from $3.55 to $3.56.
... More